S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Industrials

X-Rite Acquired by Danaher (XRIT, DHR)

Photo of Paul Ausick
By Paul Ausick Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Color technology provider X-Rite Inc. (NASDAQ: XRIT), owner of the widely used Pantone color system, has agreed to be acquired by conglomerate Danaher Corp. (NYSE: DHR) for $5.55/share in a deal worth about $625 million. The acquisition includes Danaher’s assumption of X-Rite’s debt net of cash. The acquisition is expected to close in the second quarter.

The all-cash tender offer is expected to begin within 5 days and represents a 39% premium over X-Rite’s closing price of $4/share last night. According to the announcement 68% of X-Rite’s voting shareholders intend to tender their shares in the offer.

Shares of X-Rite are up 38.5% at $5.54 in pre-market trading. The company’s 52-week range is $3.26-$5.03. Shares of Danaher are unchanged this morning at $54.59 in a 52-week range of $39.34-$56.45.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk
David Beren |

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk
3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026
Don Lair |

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

Continue Reading

Jon C. Ogg |

Rite Aid… When Debt Offerings Are Good (RAD)

If you just saw the headlines that Rite Aid Corporation (NYSE: RAD) was going to offer another $481 million in…
Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?
Jon C. Ogg |

Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?

If there is one former Dow Jones industrial average leader that is in need of serious help, look no further…
Paul Ausick |

What Danaher Gets by Paying $21.4 Billion for GE Biopharma Business

Medical device maker Danaher has agreed to acquire GE's biopharma business for $21.4 billion in cash. The transaction is expected…
Chris Lange |

Rite Aid PBM Purchase Differentiates It From CVS and Walgreens

Rite Aid has announced that it will acquire EnvisionRx for $2 billion from the private equity firm TPG Capital.
Are HD Supply Shareholders Getting Enough to Return to the Home Depot Fold?
Chris Lange |

Are HD Supply Shareholders Getting Enough to Return to the Home Depot Fold?

HD Supply shares jumped on Monday after the company announced that it would be acquired by Home Depot.
Chris Lange |

Seagate Moves to Acquire Dot Hill

The companies announced late Tuesday that they entered into a definitive agreement under which a subsidiary of Seagate will commence…
M&A Verdict: Danaher Gets Better Side of the Deal Than GE in Life Sciences Unit Sale
Jon C. Ogg |

M&A Verdict: Danaher Gets Better Side of the Deal Than GE in Life Sciences Unit Sale

Investors and speculators just love a good merger and acquisition story. The story of General Electric selling its Life Sciences…
Rite Aid Buyout Hopes Now Look More Likely, With Serious Potential Upside
Jon C. Ogg |

Rite Aid Buyout Hopes Now Look More Likely, With Serious Potential Upside

If you just trust what Walgreens said after earnings, the Rite Aid acquisition may be closer to completion than almost…
Jazz Pharma Pays $1.5 Billion for Celator
Paul Ausick |

Jazz Pharma Pays $1.5 Billion for Celator

Jazz Pharmaceuticals announced Tuesday morning that it has reached a definitive agreement to acquire Celator Pharmaceuticals for about $1.5 billion.

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618